Patent Assignment
Reel/Frame 073326/0400
Nunc Pro Tunc Assignment
Recorded: 2025-12-29
Pages: 6
Assignor
BABU, YARLAGADDA
Executed: 2025-12-11
Assignee
BIOCRYST PHARMACEUTICALS, INC.
4505 EMPEROR BLVD, SUITE 200, DURHAM, NORTH CAROLINA, 27703
Covered Property
(1)
Plasma Kallikrein Inhibitors and Methods of Use Thereof in Ocular Disorders
Patent:
12,589,093 →
Application:
17/602,674 →
Publication:
US 2022/0160694
PCT:
PCT/US2020/027287 ↗
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 6, 2021
From: CLEARSIDE BIOMEDICAL, INC
To: BYOCRYST PHARMACEUTICALS, INC
Reel/Frame 057714/0512 →
Security Interest
Apr 18, 2023
From: BIOCRYST PHARMACEUTICALS, INC.
To: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
Reel/Frame 063359/0174 →
Release of Grant of Security Interest in Patents
Apr 18, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063362/0550 →
Release of Security Interest
Apr 19, 2023
From: ATHYRIUM OPPORTUNITIES III CO-INVEST 1 LP
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 063371/0979 →
Assignment of Assignor's Interest
Dec 29, 2025
From: KANSARA, VIRAL; MCELHENY, RICK
To: CLEARSIDE BIOMEDICAL, INC.
Reel/Frame 073326/0670 →
Assignment of Assignor's Interest
Dec 29, 2025
From: CLEARSIDE BIOMEDICAL, INC.
To: BIOCRYST PHARMACEUTICALS, INC.
Reel/Frame 073326/0737 →
Security Interest
Jan 23, 2026
From: BIOCRYST PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 074485/0651 →